Attached files
| file | filename |
|---|---|
| 10-K - 10-K - BRAINSTORM CELL THERAPEUTICS INC. | v216719_10k.htm |
| EX-23 - EX-23 - BRAINSTORM CELL THERAPEUTICS INC. | v216719_ex23.htm |
| EX-10.38 - EX-10.38 - BRAINSTORM CELL THERAPEUTICS INC. | v216719_ex10-38.htm |
| EX-10.39 - EX-10.39 - BRAINSTORM CELL THERAPEUTICS INC. | v216719_ex10-39.htm |
| EX-10.37 - EX-10.37 - BRAINSTORM CELL THERAPEUTICS INC. | v216719_ex10-37.htm |
| EX-10.40 - EX-10.40 - BRAINSTORM CELL THERAPEUTICS INC. | v216719_ex10-40.htm |
| EX-31.1 - EX-31.1 - BRAINSTORM CELL THERAPEUTICS INC. | v216719_ex31-1.htm |
| EX-32.2 - EX-32.2 - BRAINSTORM CELL THERAPEUTICS INC. | v216719_ex32-2.htm |
| EX-31.2 - EX-31.2 - BRAINSTORM CELL THERAPEUTICS INC. | v216719_ex31-2.htm |
EXHIBIT 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
In connection with the accompanying Annual Report on Form 10-K of Brainstorm Cell Therapeutics Inc. for the year ended December 31, 2010, the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
(1) such Annual Report on Form 10-K for the year ended December 31, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in such Annual Report on Form 10-K for the year ended December 31, 2010 fairly presents, in all material respects, the financial condition and results of operations.
|
March 31, 2011
|
/s/ Adrian Harel
|
|
|
Name:
|
Adrian Harel
|
|
|
Title:
|
Chief Executive Officer
|
|
|
(Principal Executive Officer)
|
||